QScreen AI Finalizes Tiered Screening System as US Institutional Partnerships Progress

Four Consecutive Monthly Development Milestones Reached

QScreen AI has accelerated its product development, announcing the finalization of its tiered screening architecture as the fourth successive milestone within four months. The company reported completing full platform integration of its three signal modalities in April, deploying passive voice analysis in May, receiving US Patent No. 12,640,164 last week, and now delivering the tiered architecture that operationalizes the patented method into a deployable institutional solution.

This rapid progression through its product roadmap signals movement toward commercialization. Each milestone addresses specific functional and regulatory needs: platform integration established the technical base, passive voice analysis enhanced screening capabilities, the patent grant secured intellectual property rights, and the tiered architecture finalized the institutional deployment framework.

Tiered Screening Model: 90-Second Initial Gate with Escalation

Central to QScreen's architecture is a two-stage screening process designed for efficiency in shift-based institutional settings. Every worker undergoes a rapid readiness test lasting about 90 seconds using the patented single-camera method on standard laptops or tablets with webcams accessible through a web browser—no installation required. Clear results are processed immediately, while ambiguous outcomes trigger an extended assessment.

The escalation tier is the architecture's key feature. Instead of repeating the initial test, the extended assessment evaluates distinct physiological markers including smooth-pursuit eye tracking, response inhibition, and sustained attention. This extended evaluation is offered once per session under site-configured policies and is not intended as an appeal mechanism. Second-stage results can confirm or contextualize first-stage concerns but cannot overturn them. Certain critical safety signals bypass escalation and are routed directly for human review.

Human Oversight and Documentation Throughout the Process

QScreen's design philosophy emphasizes that the software identifies concerns, collects evidence, and documents findings, while a trained supervisor or licensed professional makes the final decision. No worker is ever removed from duty solely by algorithmic determination. Each screening stage and the final human decision are logged and displayed side-by-side in the supervisor console.

This approach addresses operational and fairness concerns. Operationally, it solves the challenge of screening large workforces during shift changes: comprehensive five-minute assessments for every worker are impractical, whereas a 90-second initial screen for all with extended assessments for ambiguous cases enables full workforce screening within shift-start periods. From a fairness perspective, ambiguous initial results trigger a structured due-process pathway with detailed assessments before supervisor interaction, uniformly applied and fully documented.

US Institutional Partner Engagement via Southeastern Channel

QScreen's collaboration with Global Frontier Advisors has generated a focused pipeline of prospective institutional and industrial evaluators in the southeastern United States. This channel strategy supports the company's near-term goal of securing its first signed evaluation agreement. COO Dr. Rahul Kushwah plans in-person platform demonstrations in the region in the coming weeks as part of this US channel initiative.

Alongside US outreach, QScreen is engaging directly with provincial correctional health authorities in Canada. The tiered architecture forms the core of the commercial model, with site licensing based on workforce coverage rather than per-test billing. This licensing strategy has been shared with US channel partners as part of the company's commercial positioning.

Browser-Based Deployment on Existing Hardware Without Installation

A notable technical advantage is the platform's deployment model. QScreen's screening system runs in a web browser on standard hardware—laptops or tablets with webcams—that institutional partners already possess. No installation or proprietary hardware is required, significantly reducing deployment complexity and capital expenditure for customers.

The patented single-camera method enables this hardware efficiency. By requiring only webcam and browser access, rather than specialized equipment or IT infrastructure changes, QScreen offers a solution ready for immediate deployment within existing workplace and institutional environments. This aligns with the company's commercial strategy of building "for deployment" rather than solely for detection.

Robust Patent Protection and Intellectual Property Portfolio

QScreen's technology is supported by two granted US patents. Most recently, US Patent No. 12,640,164 was awarded, protecting the core patented method implemented in the tiered architecture. This patent provides legal safeguards for QScreen's proprietary screening technology and may create barriers to competitors in this technical domain.

Dr. Kushwah emphasized that the patent estate underpins the technology demonstrated to institutional buyers, forming a key part of QScreen's value proposition and distinguishing it from competitors in the institutional screening market.

Designed for Operational Feasibility in Shift Change Settings

The tiered architecture addresses real-world operational challenges. Conducting comprehensive assessments on every worker each shift is impractical at scale. The 90-second initial gate for all, with extended assessments reserved for ambiguous cases, enables screening of entire workforces within typical shift-start windows while focusing measurement time where needed.

This operational design departs from detection-only methods that may be theoretically thorough but impractical in high-volume, time-sensitive environments. QScreen's approach accommodates workforce size, time constraints, existing hardware, and ensures decisions are made by qualified personnel. The escalation tier also provides structured due process for workers, with detailed, documented assessments preceding any supervisor discussion.

Clear Regulatory and Compliance Framework

QScreen clarifies that its platform functions as a clinical decision support tool requiring confirmation by licensed healthcare professionals before any action. The tool provides risk assessment and decision support but is not a diagnostic medical device and does not replace professional medical judgment.

Validation employed simulated scenarios and synthetic patient data; live performance may vary materially. These disclosures set clear boundaries on platform capabilities and appropriate institutional use, managing expectations for prospective partners regarding validation and performance.

Commercial Licensing Based on Workforce Coverage Model

QScreen's commercial model is based on site licensing tied to workforce coverage rather than per-test transactions. This differs from pay-per-screening models and has been communicated to US channel partners as part of the company's commercial approach. This model encourages comprehensive screening of all workers while providing predictable recurring revenue tied to workforce size rather than screening volume fluctuations.

The site licensing strategy reduces per-use friction, simplifies budgeting and forecasting for customers, and combined with the rapid 90-second screening and browser-based deployment on existing hardware, positions QScreen as operationally and financially accessible to large institutional employers and correctional facilities.